Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNS-301 + Pembrolizumab in Advanced Head and Neck Cancer
NCT04034225Phase 2Terminated
- Sponsor
- Sensei Biotherapeutics
- Start
- Nov 2019
- Primary completion
- Jun 2021
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics, Single Strain Products
- Countries
- 1
01
Overview
A Phase 2 trial of SNS-301 in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Sensei Biotherapeutics. Started Nov 2019; status: terminated.
02
Drugs
SNS-301
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT04034225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04034225.